Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Alcon Inc.NYSE: ALC
Other Non-Cash Items · Q3 FY2026 · quarter ended Sep 2026
Other non-cash items dips below year-ago levels
Q3 FY2026 other non-cash items of $42M fell 18.0% year over year, behind the +198.4% change in trailing-twelve-month other non-cash items.
Context
- Other non-cash items amounted to 1.4% of revenue in FY2025, down 2.3 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -18.0% toward the trailing-twelve-month pace of +198.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- (146M) USD
- Year-over-year change
- +60.3%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (146M) | +60.3% |
| FY2024 | 2024-12-31 | (368M) | +2.6% |
| FY2023 | 2023-12-31 | (377.78M) | -3006.0% |
| FY2022 | 2022-12-31 | 13M | +111.2% |
| FY2021 | 2021-12-31 | (116M) | — |
Other Non-Cash Items vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's LTM Sep 2026 other non-cash items of $159.73M is the 3rd largest of the 8 companies compared; the peer median is $20.34M.
- Its year-over-year change of +198.4% is the 4th highest of 8, against a peer median of +48.6%.
- Other non-cash items amounts to 1.5% of revenue for ALC, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $565.6M | +540.5% | +22.4% | 13.3% | |
| LTM Jun 2026 | $172.63M | +48.6% | — | 3.2% | |
| LTM Sep 2026 | $159.73M | +198.4% | — | 1.5% | |
| LTM Jun 2026 | $73.8M | +428.1% | +57.1% | 12.0% | |
| LTM Mar 2026 | $26.81M | -156.2% | +158.7% | 46.5% | |
| LTM Apr 2026 | $20.34M | +239.8% | +125.9% | 7.0% | |
| LTM Mar 2026 | $5.99M | -37.0% | +301.8% | 4.7% | |
| LTM Mar 2026 | $834K | -92.4% | -11.7% | 1.0% | |
| Peer median (excluding ALC) | $20.34M | +48.6% | +91.5% | 7.0% | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 376M | 335M | 974M | 1.02B | 980M |
| Depreciation & Amortization | 1.22B | 1.12B | 1.22B | 1.23B | 1.34B |
| Deferred Income Tax | 42M | 128M | (142M) | 238M | 180M |
| Stock-Based Compensation | 138M | 140M | 144M | 150M | 162M |
| Change in Working Capital | (314M) | (522M) | (431.22M) | (189M) | (240M) |
| Accounts Receivables | (198M) | (164M) | (117.41M) | (55M) | (129M) |
| Inventory | (326M) | (217M) | (289.26M) | (47M) | (156M) |
| Accounts Payables | 60M | (48M) | (54.44M) | (15M) | 116M |
| Other Working Capital | 150M | (93M) | 29.89M | (72M) | (71M) |
| Other Non-Cash Items | (116M) | 13M | (377.78M) | (368M) | (146M) |
| Operating Cash Flow | 1.35B | 1.22B | 1.39B | 2.08B | 2.27B |
| Capital Expenditures | (1.18B) | (745M) | (851M) | (670M) | (663M) |
| Acquisitions (Net) | 480M | (666M) | (10M) | (220M) | (700M) |
| Purchases of Investments | (19M) | (50M) | (248.7M) | (278M) | (136M) |
| Sales of Investments | 1M | 81M | 2M | 9M | 158M |
| Other Investing Activities | (480M) | (485M) | (177.3M) | (205M) | (123M) |
| Investing Cash Flow | (1.2B) | (1.87B) | (1.09B) | (1.17B) | (1.34B) |
| Debt Repayment | (63M) | 166M | (7M) | (137M) | (96M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (22M) | (50M) | (49M) | (47M) | (723M) |
| Dividends Paid | (54.11M) | (100M) | (116M) | (130M) | (166M) |
| Other Financing Activities | 16.11M | (24M) | (39M) | (8M) | (134M) |
| Financing Cash Flow | (123M) | (8M) | (211M) | (322M) | (1.12B) |
| Effect of Forex Changes | (6M) | 61M | 31M | (6M) | 43M |
| Net Change in Cash | 18M | (595M) | 114M | 582M | (149M) |
| Free Cash Flow | 165M | 472M | 537M | 1.41B | 1.61B |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.